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Abstract: The increased use of non-steroidal anti-inflammatory drugs (NSAIDs) has resulted in 
their ubiquitous presence in the environment. The toxicological properties of these two widely 
prescribed NSAIDs, namely - racemic ketoprofen (rac-KP) and its enantiomer S(+)-ketoprofen 
(dexketoprofen, DKP) were evaluated. Firstly, by acute and chronic toxicity tests using three 
representative model organisms (Vibrio fischeri, Pseudokirchneriella subcapitata and 
Ceriodaphnia dubia). Secondly, by evaluating the responses of biotransformation systems and 
multidrug resistance associated proteins (MRP1/MRP2) using the PLHC-1 fish hepatic cell-line. 
Toxicity data from both acute and chronic DKP exposure indicated higher sensitivity through 
inhibition of bioluminescence and algal growth and through increased mortality/immobilization 
compared to rac-KP exposure. The growth inhibition test showed that rac-KP and DKP exhibited 
different values for EC50 (240.2 µg/L and 65.6 µg/L, respectively). Furthermore, rac-KP and 
DKP did not exert cytotoxic effects in PLHC-1 cells, and produced compound-, time- and 
concentration-specific differential effects on CYP1A and GST levels. For CYP1A, the effects of 
rac-KP and DKP differed at transcriptional and catalytic level. Exposure to rac-KP and DKP 
modulated MRP1 and MRP2 mRNA levels and these effects were also dependent on compound, 
exposure time and concentration of the individual drug. The present study revealed for the first 
time, the interactions between these NSAIDs and key detoxification systems, and different 
sensitivity to the racemic mixture compared to its enantiomer. This article is protected by 
copyright. All rights reserved 
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INTRODUCTION 
The presence of pharmaceutical compounds in wastewater treatment plants (WTP) and 
surface water (SW) is an emerging environmental issue that poses as a potential risk for aquatic 
ecosystems and human health [1]. There is a large amount of data on the beneficial and adverse 
effects of pharmaceuticals, but there is limited information about the impact of these compounds 
to non-target organisms in the environment. Parent pharmaceutical compounds and their 
metabolites have been detected in surface, drinking and ground water, from not only hospitals 
and domestic sewage treatment plant (STP) effluents, but also from landfill leachates and 
manufacturing residues [2,3]. There is evidence that many of these substances are neither 
degraded in STPs nor in the environment [2,3]. Due to their widespread application, these 
substances can reach aquatic environments primarily via sewage effluents after human or farm 
animal consumption and subsequent excretion. The consumption phase represents the biggest 
contributor to the emissions of medicinal products into the environment [4]. Once in wastewater, 
STPs can partly eliminate or remove medicinal product residues, but some traces are detectable 
[5].  
Depending on the physical and chemical properties of either the compounds or the host 
compartments, these pharmaceuticals can be biotransformed and the resulting metabolites may 
have different fates in the environment [6]. Recent studies have demonstrated the presence of 
measurable concentrations of medicinal drugs in ng/L-µg/L range, both in surface and sewage 
waters [5]. Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used pharmaceuticals, 
mainly due to their analgesic, antipyretic and anti-inflammatory properties [7]. Most of these 
drugs act as non-selective inhibitors of cyclooxygenase (COX) isoforms. COX-1 is constitutively 
expressed in cells under physiological conditions, while COX-2 is induced by cytokines, 
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mitogens and endotoxins under pathological conditions, such as inflammation. Both COX-1 and 
COX-2 are involved in the synthesis of different inflammatory mediators [8]. Based on estimated 
annual production of several kilotons, NSAIDs are the sixth top-selling class of drugs worldwide 
[9]. Due to the rising usage and associated pharmacokinetics (half-life, urinary and faecal 
excretion, metabolism and low removal efficiency STPs), several NSAIDs can reach detectable 
concentrations in aquatic environments [10]. Ketoprofen (KP) is one of the most widely used 
NSAIDs and is found as a racemic mixture (rac-KP), comprising of the two enantiomers: R(-)-
KP and S(+)-KP [1]. Rac-KP has been detected at low concentrations in STPs (ranging from 0.41 
- 5.7 µg/L) and at low concentrations in the environment [1]. 
The therapeutic effect of the rac-KP resides almost exclusively in the S(+)-enantiomer 
since the R(-)-enantiomer lacks such activity [11]. A useful index of the relative anti-
inflammatory activity of the individual enantiomers of a chiral NSAID was obtained in vitro by 
comparing their effects on the COX binding site. This comparison showed that the activity 
resided with the enantiomer possessing the S(+) configuration, since the R (-) enantiomer 
produced no interaction with the COX binding site [12]. Additionally, the S(+)-KP is absorbed 
rapidly from the gastrointestinal tract, and is consequently characterized by a quick onset of 
biological action [13]. The enantiomeric distribution of NSAIDs in the aquatic environment 
depends on the extent of both the chiral inversion of R-enantiomers during human metabolism 
and the preferential biodegradation of S-enantiomer during wastewater treatment [14]. Since the 
efficacy is due to the S(+)-enantiomer, the marketing of the dextrorotatory enantiomer 
(dexketoprofen: DKP) has become a major scientific and economic interest [15]. The acute 
toxicity of the most common NSAIDs, including acetylsalicylic acid, diclofenac and ibuprofen, 
has been tested on non-target organisms belonging to different trophic levels [16]. Overall, these 
studies generally demonstrated that NSAIDs have low acute toxicity based on calculated short-
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term 50% effect concentration (EC50), ranging between 10 and 100 mg/L [16]. Nevertheless, 
considering that the effective concentrations for these tests are much higher than those currently 
detected in the environment, chronic effects are certainly more environmentally relevant. 
An increasing number of studies have evaluated several sub-lethal effects induced by 
NSAIDs on non-target organisms, such as cnidarians [17], cladocerans [16], mussels [18, 19] and 
fish [20], highlighting that these compounds alone or in combination can produce toxic effects 
related to oxidative stress, reproduction, cyto-genotoxicity and survival. The use of either acute 
or chronic bioassays on standard test organisms represents a significant approach in the definition 
of ecological risk in the aquatic environment. Acute bioassays using algae, crustacean and fish 
are commonly used for assessing the potential impact of pharmaceuticals on the environment, 
however there is a lack of studies on chronic toxicity and in vitro biotransformation effects. 
Moreover, the traditional toxicity tests are generally not designed for the specific modes of 
actions of each pharmaceutical and known side effects in humans are not taken into consideration 
[1]. Fish cell lines from different species and different organs have been used for cytotoxicity 
assays [21] and shown to provide the basal toxicity information, comparable to mammalian cells 
when correlating the EC50 values [22]. The interactions between several pharmaceuticals on the 
functions and regulation of cytochrome P450 1A (CYP1A), glutathione S-transferase (GST) and 
efflux pumps has been used in fish cell lines to study their potential consequences in terms of cell 
toxicity [20,23,24]. Thus, the aims of this study were to evaluate the ecotoxicity of rac-KP and 
DKP in freshwater organisms using two different approaches. Firstly, we applied acute and 
chronic bioassays on model freshwater organisms (Vibrio fischeri, Pseudokichneriella 
subcapitata, Ceriodaphnia dubia). Secondly, we used in vitro fish cell model (Poeciliopsis lucida 
hepatocellular carcinoma, PLHC-1) to evaluate the toxicological responses on function and 
regulation of CYP1a, GST and efflux pumps (MRP1 and MRP2). 
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MATERIALS AND METHODS 
Chemicals and reagents  
Racemic mixture of (RS)-ketoprofen, 2-(3-Benzoylphenyl) propionic acid (CAS No. 
22071-15-4) and its enantiomer dexketoprofen, (S)-(+)-ketoprofen (CAS No. 22161-81-5) were 
purchased from Sigma-Aldrich (Milan, Italy). Stock standard solutions of pharmaceuticals were 
prepared in deionized water at 10 mg/L and stored at 4°C. Amber glassware was used to prevent 
light degradation of pharmaceuticals. Fetal bovine serum (FBS) (heat inactivated), penicillin–
streptomycin (5000 U/mL), trypsin (2.5%), Eagle’s Minimum Essential Medium (MEM), 
Dimethyl sulfoxide (DMSO), EDTA ethylene diamine tetra acetic acid, 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyl-tetrazolium bromide (MTT), 1-chloro-2,4-dinitrobenzene (CDNB), 
Ethoxyresorufin, Phenol, Potassium dichromate, Isopropyl alcohol (IPA), Hexane and Formic 
acid were obtained from Sigma-Aldrich.  
 
Ecotoxicological Bioassays 
An ecotoxicological test battery (bacteria, algae, daphnids) was adopted for toxicity 
evaluation, in order to define effect concentrations for pharmaceuticals. 
Inhibition of bioluminescence (V. fischeri) 
The inhibition of bioluminescence test was performed according to the ISO procedures 
[25]. Bacteria were obtained from Ecotox LSD (Pregnana Milanese, Italy). For identification of 
ecotoxicological parameters such as EC20/50 a full test was performed with a dilution series (from 
3.90 µg/L to 2000 µg/L, 10 dilutions). Bacteria were exposed to each dilution and their light 
emission was determined after 15 minutes incubation and compared to an aqueous control. The 
tests were performed at 15°C (pH 6–8) in triplicate. All measurements were performed using the 
M500 luminometer. The instrument was interfaced with a PC operating with the Microtox® 
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Omni 1.16 software, for acquisition, data handling and EC50 calculation (Least Square Method). 
EC50 values are expressed as means and confidence limits (95 %) of three replicate 
determinations. Phenol was used as the reference toxicant. 
Growth inibithion (P. subcapitata) 
The inhibition of growth was evaluated according to the protocol described in ISO 
procedures [26] with slight modifications. P. subcapitata strain CCAP 278/4 was purchased from 
the reference center CCAP (Culture Collection of Algae and Protozoa-Scottish Association for 
Marine Science/SAMS Research Services Ltd). P. subcapitata was cultured in 3N-BBM+V 
(Bold Basal Medium with 3-fold Nitrogen and Vitamins; modified). Late logarithmic phase algae 
were inoculated in 25 mL fresh medium to an initial concentration of 10000 cells/mL and were 
grown at 20±2 °C under cool white fluorescent continuous light of 7000 lux with slow shaking 
for 96 h of incubation. The algal growth was measured as number of cells/mL and cells were 
counted with a Bürker Counting Cell Chamber (HBG, Germany), using an optical microscope 
(Olympus CH-2). For the determination of the effective concentration causing 5%, 10%, 20% 
and 50% of growth inhibition (EC5/10/20/50) and the lowest- and no effect-observed effect 
concentration (LOEC and NOEC), a full test was performed by serial dilutions (from 1.95 µg/L 
to 2000 µg/L). Experiments on rac-KP and DKP were performed in triplicate. Potassium 
dichromate was used as reference toxicant. The endpoint was the inhibition of growth (cells/mL) 
after 96 h of incubation. Assays were considered valid when the number of control cells 
increased by at least 16-fold over 96 h.  
Acute and chronic assays (C. dubia) 
For the acute toxicity assay, C. dubia (neonates < 24 h old) were exposed to high 
concentrations of rac-KP and DKP ranging from 1560 µg/L to 100000 µg/L in 48 h static tests, in 
order to assess lethal effects. Rac-KP and DKP stock solutions of 100 g/L were prepared in 
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acetone and then diluted in culture medium to obtain the concentrations tested. Organisms were 
obtained from Ecotox LSD (Pregnana Milanese, Italy) as dormant eggs (ephippia). Three 
replicates each containing ten organisms were assigned to the experimental groups (rac-KP and 
DKP), the control group (culture medium) and the solvent control group (acetone: 0.1% v:v). 
After 48 h, we evaluated the immobilization/mortality using a stereo-microscope Leica M80 
(German Company). The number of dead organisms in the control group did not exceed 10%. 
Potassium dichromate was used as reference toxicant. The test was performed in according to US 
EPA 2002a [27].  
For the chronic toxicity assay, third brood neonates (< 24 h old) were exposed for 7 days 
at different concentrations of rac-KP and DKP ranging from 1 to 1000 µg/L. The lowest 
concentrations were similar to concentrations detected in the environment (ranging from 0.41 to 
5.7 µg/L) [1]. Ten replicates with one organism per 30 mL in a glass beaker of 100 mL were 
assigned to each treatment. Organisms were fed once daily with yeast and a P. subcapitata algal 
suspension. All test solutions were renewed daily starting from the stock solutions prepared 
before the start of the test. The number of neonates in each beaker was counted and recorded 
every day. Neonates were then discarded and the media renewed. Test solutions were 
characterized by alkalinity 120-138 mg/L as CaCO3, hardness 150-184 mg/L as CaCO3, DO 
8.22-10.13, and pH 7.52-8.60 at 25°C. At least 80% of all control organisms survived, and 60% 
of surviving control females produced at least three broods, with an average of 15 or more 
neonates per surviving female. The test was performed in according to US EPA 2002b [28].  
Analytical chemistry 
Concentrations of rac-KP (R(-)/S(+)-KP) and DKP (S(+)-KP) were measured in 
experimental media solutions for the chronic assays (algae and crustacean). Enantiomers were 
measured via an enantioselective HPLC-UV detection method. Samples were filtered and 
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extracted with SPE (Strata™-XL 100 µm Polymeric Reversed Phase) followed by HPLC analysis 
with a chromatographic system that consisted of a Series 200 PerkinElmer gradient Pump 
coupled to a Series 200 PerkinElmer variable UV detector, which was set at 254 nm. The normal-
phase column was a Lux® Amylose-1, LC Column (5 μm, 250 x 4.60 mm) (Phenomenex, CA, 
USA). The column was kept at room temperature. Turbochrome® software was used for data 
processing. A 20 μL injection was used each time. The mobile phase consisted in hexane-
isopropyl alcohol with 0.1 % of formic acid. The detection limit, calculated as signal-to noise 
ratio 3:1, was 0.05 µg/L.  
PLHC-1 cell-line  
The PLHC-1 cell line, obtained from the American Type Culture Collection (ATTC CRL 
2406), is derived from the hepatocellular carcinoma of the Topminnow Poeciliopsis lucida [29]. 
They were routinely grown at 30°C in Eagle’s Minimum Essential Medium (MEM) 
supplemented with 5% fetal bovine serum (FBS) and 1% penicillin-streptomycin (5000 U/mL) in 
a 5% CO2 humidified atmosphere. The cells were grown in 75 cm
2 culture flasks and subcultured 
every 3–4 days after harvesting with trypsin (0.05%) and ethylenediamine tetraacetic acid 
(EDTA) (0.53 mM) in phosphate-buffered saline solution (PBS) and diluted 3–4 times. Cells 
were used at 75% monolayer confluency. 
Cell viability assay 
Mitochondrial capacity to reduce MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) to formazan was used as a measure of cell viability [30]. Cells 
were seeded at rate of 30000 or 50000 cells per well (depending on the duration of the exposure) 
in 96-well plate and allowed to attach for 24 h. Cells were then exposed to rac-KP and DKP, 
which were dissolved in culture medium at different concentrations (0.1, 1, 10, 100 and 1000 
μg/L). Plates were incubated for 48 and 72 h. The experiments were performed in triplicates. 
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After exposure, cells were incubated for 4 h with 0.5 mg/mL MTT dissolved in complete growth 
medium. The MTT solution was then replaced with 200 μL DMSO to dissolve the insoluble 
formazan crystals, and the plate was read in a spectrophotometric plate reader at 570 nm. Cell 
viability was given as relative survival (% viability) of exposed cells compared to control cells. 
Phase I and II biotransformation responses 
Ethoxyresorufin-O-deethylase (EROD) activity was used as markers for phase I 
biotransformation activity. Cells were seeded at the rate of 30000 or 50000 cells per well and 
exposed in a black fluorometric 96-well plate for 72 and 48 h respectively, to various 
concentrations of the rac-KP and DKP (0.1, 1, 10, 100 and 1000 µg/L).  The experiments were 
performed in triplicates. After exposure, the medium was removed and cells were incubated in 
100 µL of 0.3 mM NADPH (dissolved in PBS) for 10 minutes at 37°C. The reaction was then 
started by adding 1 μL of the substrate ethoxyresorufin (EROD) (180 μM in DMSO) and 
fluorescence was measured in a microplate reader for 20 min (ex: 535 nm; em: 590 nm) [31]. 
Total amount of protein was determined with the method of Bradford, using bovine serum 
albumin (BSA) as the standard. Quantification of the activity was made using a calibration curve 
with 7-hydroxyresorufin. The activities were expressed as a percentage of the control. 
Glutathione-S-transferase (GST) activity was measured on cell lysates following the 
spectrophotometric assay described by Habig et al. (1974) [32]. Cells were seeded at the rate of 
300000 or 500000 cells per well and exposed in a 6-well plate for 72 and 48 h respectively, to 
different concentrations of the rac-KP and DKP (0.1, 1, 10, 100 and 1000 µg/L). The experiments 
were performed in triplicates. After exposure, cells were harvested and resuspended in 20 mM 
Tris buffer pH 7.4, 100 mM NaCl, 1 mM EDTA 1x PIC (protease inhibitor cocktail). Samples 
were then frozen and thawed three times. Cell lysates were collected after centrifugation at 10000 
x g for 30 min at 4°C. GST assay reaction contained 100 mM KH2PO4 pH 6.5, 1 mM GSH, 1 
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mM CDNB (1-chloro-2,4-dinitrobenzene) dissolved in DMSO and 20 µL of total cell lysate. The 
conjugation of glutathione to CDNB was measured at 340 nm. The specific activity was 
calculated using the extinction coefficient of 9.6 mM-1cm-1. 
RNA isolation and cDNA synthesis 
Cells were seeded at the rate of 150000 or 300000 cells per well and exposed in a 24-well 
plate for 72 and 48 h respectively, to different concentrations of rac-KP and DKP (0.1, 1, 10, 100 
and 1000 µg/L). The experiments were performed in triplicates. After exposure total RNAs from 
cells were isolated using Direct-zol RNA MiniPrep isolation kit (Zymo Research, Irvine, CA, 
USA). The RNA was quantified using NanoDrop® ND-1000 UV–vis Spectrophotometer 
(NanoDrop Technologies, Wilmington, DE, USA) and the quality of RNA was assessed by 
260/280 ratio. Total cDNA for the real-time PCR reactions were generated from 0.1 μg DNase-
treated total RNA from all samples using poly-T primers from iScript cDNA Synthesis Kit as 
described by the manufacturer (Bio-Rad). The reverse transcription was conducted by incubating 
the reaction mixture in the Thermal Cycler (Bio Rad), under the following conditions: 5 min at 
25°C, 30 min at 42°C, and 5 min at 85°C. 
Quantitative real-time PCR analysis (qRT-PCR) 
Quantitative (real-time) PCR was performed with gene-specific primers (cyp1a, mrp1 and 
mrp2, as shown in Table 1) using the Mx3000P REAL-TIME PCR SYSTEM (Stratagene, La 
Jolla, CA, USA). The 3 step real-time PCR program included an enzyme activation step at 95 °C 
(10 min) and 40 cycles of 95 °C (30 s), 60 °C depending on target gene (15 s), and 72 °C (15 s), 
followed by a melting analysis at 95 °C for 1 min, 65 °C (30 s) and thereafter decreasing 
fluorescence detection with increasing temperature between 65–95 °C. Controls lacking cDNA 
template was included to determine the specificity of target cDNA amplification. Cycle threshold 
(Ct) values obtained were converted into mRNA copy number using standard plots of Ct versus 
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log copy number. The criterion for using the standard curve was based on equal amplification 
efficiency with unknown samples and checked prior to extrapolating unknown samples to the 
standard curve. Standard plots were generated for each target sequence using known amounts of 
plasmid containing the amplicon of interest, following an already validated method [33]. Data 
obtained from triplicate runs for target cDNA amplification were expressed as percentage of the 
control. 
Statistical Analysis 
EC5/10/20/50 values for algal inhibition of growth and their 95% confidence limits were 
calculated by the linear interpolation method. Statistical analyses were performed using 
GraphPad Prism, version 6.01 (GraphPad Software Inc. 2012). Data were tested for normality 
and variance homogeneity. One-way ANOVA was performed for the chronic experiment with 
crustaceans to evaluate statistical differences (p < 0.05) between control and exposure groups 
using the Dunnett’s Multiple Comparison Test. Two-way ANOVA was performed to investigate 
possible time-effect and dose-effect relationships for the biomarker endpoints using time 
exposure (48 h and 72 h) and rac-KP and DKP concentrations as variables. The Two-way 
ANOVA was followed by Tukey post-hoc test to evaluate significant differences (p < 0.05) 
between treated and related time control, as well as among time at the same concentration. The 
Pearson’s correlation test was performed on all the measured variables to investigate dose-
dependency.  
RESULTS 
Inhibition of bioluminescence on V. fischeri 
In our preliminary analysis with rac-KP and DKP, we observed that bioluminescence, 
expressed as RBU (relative bioluminescence units at 490 nm), was not detectable in the absence 
of bacteria (data not shown). The assay performed with the reference toxicant (phenol) confirmed 
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sensitivity within the limit of acceptability (13-26 mg/L) with an EC50 value of 18.4 mg/L. In the 
presence of V. fischeri, we did not observe acute toxicity after 15 min incubation at rac-KP 
concentration between 3.9 - 2000 µg/L (Table 2). However, a hormetic effect (I% = 17.9) was 
detected at the highest rac-KP concentration. On the contrary, DKP concentration of 500 µg/L 
and above, inhibited bioluminescence and therefore the EC50 value of DKP was calculated to be 
1046 µg/L (95 % confidence limit (C.L.): 373 - 2935 µg/L, Table 2).  
Growth inhibition on P. subcapitata 
The algal strain was tested with the reference toxicant (potassium dichromate) showing an 
EC50 value of 0.4 mg/L within the limit of acceptability (0.18-1.8 mg/L). The NOEC, LOEC and 
EC5/10/20/50 values are summarized in Table 3. DKP exhibited an EC50 value of 3.7-fold lower than 
rac-KP. The reported inhibition (%) of growth in P. subcapitata by plotting rac-KP, DKP and the 
S(+) fraction of rac-KP is shown in Figure 1. Measured concentrations of individual 
pharmaceutical compounds in algal media are presented in Table 4. The mean recovery 
percentages (%) for each exposure condition were 99.1 ± 4.6 % (Supplemental data, Table S1 
and S2).  
Acute and chronic toxicity effects on C. dubia 
The crustaceans were tested with the reference toxicant (potassium dichromate) showing 
an EC50 value of 1.1 mg/L within the limit of acceptability (0.18-1.8 mg/L). The effect of 48 h 
acute toxicity (mortality/immobilization) on C. dubia exposed to serial dilutions of rac-KP and 
DKP is shown in Table 5. The experimental control data is shown to be within the acceptability 
range of the assay. However, the obtained data were unsuitable for the regression model due to 
the absence of a dose-response trend. Thus, no EC values have been calculated in the acute 
exposure. The maximum mortality percentage observed was 40- and 60 % for rac-KP and DKP, 
respectively. The effect of 7-day chronic toxicity on C. dubia exposed to environmental relevant 
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concentrations of rac-KP and DKP is shown in Table 6 and 7, respectively. Control values are 
within the acceptability range of the assay. After 7-day exposure time period, the cumulative 
mortality rate was 20% for rac-KP at the highest tested concentration of 1000 µg/L, while a 20- 
and 40% mortality rate was observed for DKP at 100 and 1000 µg/L, respectively. For both rac-
KP and DKP, the most dramatic effect was observed on fecundity, showing a significant decrease 
in the number of offspring/female of C. dubia exposed to 1000 µg/L (rac-KP) and at 100- and 
1000 µg/L for DKP. The percentage of reproduction inhibition relative to the control is reported 
in Table 6 and 7. For the chronic toxicity assay, the measured concentrations of individual 
pharmaceutical compound in crustacean media are presented in Table 8. The mean recovery 
percentages for each exposure condition were 98.6 ± 10.6 % (Supplemental data, Table S3 and 
S4). 
Effects on PLHC-1 cell line  
MTT cell viability assay showed that cells exposed to serial dilutions of rac-KP and DKP 
for 48 h produced high survival rates at all the tested concentrations, except at 1000 µg/L, where 
~65% of viability was observed.  Cells exposed for 72 h to rac-KP and DKP exhibited ~70% cell 
viability at 10, 100 and 1000 µg/L. 
Effects on biotransformation responses in PLHC-1 
The phase I biotransformation response was measured at transcript (mRNA) and 
functional (EROD activity) levels (Fig. 2). The cyp1a transcript showed a rac-KP concentration-
dependent increase at 48 h (Pearson r=0.93; R2=0.86; p<0.05). Exposure of cells to rac-KP for 
48 h at 1000 µg/L, and for 72 h at 10, 100 and 1000 µg/L resulted in significantly increased 
cyp1a levels, compared to control cells (Fig. 2A). On the other hand, the EROD activity of rac-
KP exposed cells was significantly decreased, compared to control cells after 48 h exposure to 
10, 100 and 1000 µg/L rac-KP (Fig. 2B). Interestingly, no significant changes in EROD activity 
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were observed after 72 h exposure to rac-KP (Fig. 2B). Additionally, cells showed significantly 
different cyp1a mRNA levels and EROD activities between 48 and 72 h exposure to the same 
rac-KP concentrations (10, 100 and 1000 µg/L ). For DKP, a significant decrease of cyp1a 
mRNA expression, below control level, was observed when cells were exposed to concentrations 
between 0.1-100 µg/L at both 48 and 72 h (Fig. 2C). However, at 1000 µg/L, DKP produced a 
significant increase of cyp1a mRNA expression, above control level, at both 48 and 72 h of 
exposure (Fig. 2C). Furthermore, for DKP, a concentration-dependent trend was observed for 
cyp1a mRNA at 48 h and 72 h (Pearson r=0.97; R2=0.95; p < 0.05 and Pearson r=0.98, R2=0.96; 
p < 0.05, respectively). The functional CYP1A response measured as EROD activity was 
significantly decreased below control level, in cells exposed to DKP for 72 h to 10, 100 and 1000 
µg/L (Fig. 2D) and no significant changes in EROD activity were observed after 48 h exposure to 
DKP (Fig. 2D). The GST activity was used as a measure of phase II biotransformation response 
(Fig. 3). Exposure to rac-KP produced a significant increase in GST activity above control levels, 
in all tested concentrations at 48 h, while after 72 h exposure no differences in activity between 
control and treated groups were observed, except a significant decrease observed at 0.1 µg/L  
(Fig. 3A). At 48 h, the increase in GST activity was concentration-dependent (Pearson r=0.99; 
R2=0.98; p < 0.05). On the other hand, GST activity in DKP-treated PLHC-1 cells showed a 
significant increase at 48 h exposure to 100 µg/L, while the highest tested concentration of 1000 
µg/L produced a significant decrease (Fig. 3B). Interestingly, 72 h exposure to DKP produced a 
significant decrease in GST activity at all tested concentrations (Fig. 3B).  Rac-KP and DKP 
exposures showed significant time differences in GST activity. 
Effects on Multidrug resistant protein  
Changes in transcript level of the multidrug resistant protein 1 and 2 (mrp1 and mrp2) 
were evaluated (Fig. 4). The mRNA abundance for mrp exhibited time- and concentration-
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specific changes. The levels of mrp1 were significantly increased at 48 and 72 h in cells treated 
with rac-KP at 10, 100 and 100 µg/L (Fig. 4A). The mrp2 mRNA expression was significantly 
increased after 72 h to 1000 µg rac-KP/L (Fig. 4B). On the other hand, a concentration-
dependency in mrp1 and mrp2 mRNA expression was observed in PLHC-1 cells after 48 h 
exposure to DKP (Pearson r=0.99; R2=0.98; p < 0.05 and Pearson r=0.99; R2=0.99; p < 0.05, 
respectively). Particularly, a significant decrease was observed when cells were treated with DKP 
at 0.1 - 100 g/L for 48 h (Fig. 4C and D, respectively). While at 72 h exposure, there was a 
significant increase in mrp1 mRNA after exposure to the highest DKP concentration of 1000 
g/L and no changes were observed in mrp2 mRNA levels (Fig. 4C and D, respectively).  
DISCUSSION 
We have evaluated the acute and chronic effects of rac-KP and its enantiomer DKP 
through bioassay approaches with freshwater model organisms and with fish hepatocyte model 
(PLHC-1). Although the racemic mixture and corresponding enantiomers of a particular 
compound may have the same physical properties and abiotic degradation rates, they often have 
different biological activity [34]. Differences in pharmacokinetics and pharmacodynamics of the 
two enantiomers occur in mammals and significantly vary among species [35]. Additionally, 
conversion of R(-)-KP to S(+)-KP occurs in many species, but the rate of conversion varies 
between species, and in some circumstances, between individuals within a species [35]. On the 
other hand, the conversion of S(+)-KP to R(-)-KP, has only been demonstrated in mice [36]. 
Ecotoxicological assessment 
In order to define the ecotoxicological hazard assessment of rac-KP and DKP, we acutely 
or chronically exposed bacteria, algae and crustaceans to these NSAIDs. Inhibition of 
bioluminescence using V. fischeri test produced a hormetic effect at the highest tested rac-KP 
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concentration. Hormesis is a phenomenon that is defined as a stimulatory beneficial effect at very 
low concentrations of toxic chemicals [37]. However, at higher concentrations this phenomenon 
may have a harmful, beneficial or indifferent effect in biota [38]. On the contrary, V. fischeri 
exposed to DKP showed an inhibition of bioluminescence with an EC50 value of 1046 µg/L. 
There are only a few studies on exposure to rac-KP using V. fischeri and based on our 
knowledge, there are no available reports that have used DKP in ecotoxicological assays. 
However, a recent study showed an EC50 of 118 mg/L for rac-KP [39]. The authors did not report 
any hormetic effect after exposure to rac-KP, which is likely due to the high concentrations used 
in their study. Interestingly, in our study, DKP was severely toxic with an EC50 value 100–fold 
lower than the EC50 value reported by Wieczerzak and colleagues (2016) using rac-KP [39]. 
We have also evaluated whether chronic exposure (96 h) to either rac-KP or DKP would 
produce effects on the algal growth using P. subcapitata as model organism, showing that algae 
was more sensitive to DKP (EC50=65.6 µg/L) compared to rac-KP (EC50=240.2 µg/L). The 
calculated EC10 value for both rac-KP and DKP were comparable to the observed NOEC values 
for both the pharmaceuticals. While there are no ecotoxicological studies using DKP, there are 
few studies in the literature reporting the exposure of P. subcapitata to rac-KP. These studies 
reported different EC50 values, with the lowest reported 4 mg/L [40] to 24.6 mg/L and the highest 
reported 49.3 mg/L [41,42]. Our study showed an EC50 value in P. subcapitata exposed for 96 h 
to rac-KP that is 16.7-fold lower than the lowest value reported in literature. Specifically, our test 
may have revealed lower EC50 value compared to those reported in the literature, due to the algal 
growth conditions, the photo-degradation of the tested compounds, test duration and different 
methods for evaluating the endpoint, such as optical density, electronic particle counter, 
chlorophyll fluorescence or number of cells/volume unit [43]. Overall, the algae test data suggest 
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that these pharmaceuticals may not produce significant effects on primary producers, at least not 
on the algal species tested in this study. 
Subsequently, acute assays using C. dubia (48 h) revealed the highest effect on mortality 
for both rac-KP and DKP at 100 mg/L. Thus, the acute risk posed by rac-KP and DKP may 
represent a negligible environment and biota effect, since the reported environmental 
concentrations are several orders of magnitude lower than the concentrations used in this study 
[1]. This is in accordance with previous studies showing that rac-KP, diclofenac and atenolol did 
not exhibit acute toxicity on organisms when tested at 1 mg/L [24]. Moreover, a study using 
similar cladoceran species (D. magna) reported a comparable EC50 value (>100 mg/L) for rac-KP 
at pH 7.5 [44]. Finally, a chronic assay (7 d) using low rac-KP and DKP concentrations was also 
performed. C. dubia exposed to 1000 µg DKP/L showed a 45.4% of reproduction inhibition with 
mortality of 40%. A previous study in C. dubia tested rac-KP fecundity and found a NOEC value 
of 22.6 mg/L [41]. Interestingly, in our study, which tested significantly lower concentrations of 
rac-KP (≤1000 µg/L), we observed a 24.9 % inhibition in reproduction at the highest 
concentration. Since the topic of the study was to investigate environmental relevant 
concentrations of these compounds, we did not test concentrations of rac-KP and DKP higher 
than 1 mg/L. Data on bioassays showed that V. fischeri, P. subcapitata were more sensitive to 
DKP than to rac-KP. Despite that the racemic mixture rac-KP containing 50% DKP, the effects 
observed after exposure to rac-KP and DKP in bacteria and algae did not parallel this ratio 
relation. The highest sensitivity of DKP compared to rac-KP (containing 50% DKP) observed in 
Figure 1, suggest a possible enantioselective toxicity, partially due to the S(+)-enantiomer in the 
racemate.  
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Toxicological responses 
The cytotoxicity of rac-KP and DKP was assessed in PLHC-1 cells by MTT, showing the 
absence of significant effects at all tested concentrations, including 1000 µg/L (~ 4 µM). Our 
findings are consistent with previous report by Thibaut and Porte [45].  
Biotransformation enzymes play integral roles in the activation and deactivation of 
xenobiotics and drugs and their alterations markedly affects their potential risks and benefits, 
which is consequently important from a toxicological and pharmacological standpoint [46]. A 
better understanding of our observed effects of rac-KP and DKP must consider the full range of 
possible toxic and regulatory mechanisms (transcriptional, translational and post-translational 
modifications) involving the P450 function or AhR signalling pathways. For toxicological 
responses, rac-KP and DKP produced differential effects on the CYP1A at transcriptional and 
functional levels. For example, while a concentration- and time-dependent increase was observed 
at the mRNA levels, the effects on EROD activity levels were either decreased or indifferent. 
This could suggest a possible mechanism that normalize the CYP-dependent function, indicating 
a return to the normal level. Interestingly, cells exposed to DKP did not exhibit a similar 
response. There is no available information on non-target organisms about the mechanisms of 
CYP1A regulation by NSAIDs. However, the ability of rac-KP to decrease 3-methylcolanthrene 
(3-MC) induced EROD activity has been reported in rat liver [47]. Elsewhere, no significant 
effect of NSAIDs at 1 μM on EROD activity in carp liver subcellular fractions was observed 
[48]. Due to the high solubility of both rac-KP and DKP, it could be reasonably inferred that 
these compounds may not play significant roles in the phase I biotransformation pathway. With 
this in mind, given that the CYP biotransformation system metabolizes both endogenous and 
exogenous substances (including drugs), interactions between foreign chemicals and 
physiological processes are possible [49]. Thus, the relationships between induction of 
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biotransformation enzymes and possible alteration of drug efficacy deserve more attention. The 
rac-KP and DKP produced reduction in CYP1A-mediated EROD activity may represent an 
adaptive control of drug bioavailability for optimal effects, since functional CYP1A may 
metabolize rac-KP and DKP, leading to their subsequent excretion. Ultimately, further 
investigations are needed to better understand the possible involvement of the CYP system in the 
metabolism and excretion of rac-KP and DKP.  
 GST is an important phase II enzyme that uses the products of phase I reactions to form 
large endogenous molecules. The production of large endogenous molecules by GST is of major 
importance in the conjugation and subsequent elimination of drugs and endogenous compounds 
[50]. Herein, we measured GST activity levels after exposure to either rac-KP or DKP, showing 
that rac-KP produced elevated GST activity in cells exposed for 48 h, suggesting a possible 
conjugation of rac-KP or rac-KP metabolites with GSH. On the contrary, DKP significantly 
decreased GST activity, except at 48 h with 100 g/L, suggesting possible time-specific effects. 
Although phase II enzymes are crucial in eliminating NSAIDs, the interaction between GST and 
our tested pharmaceuticals is poorly understood. In mammals, it has been shown that rac-KP can 
be eliminated as either free rac-KP, conjugated (probably as a glucuronide), or as hydroxyl (OH) 
metabolite with or without conjugation [51]. In this regard, the high degree of ionization and 
solubility affects rapid excretion of the glucuronide [51]. This transformation is also known to 
modify sulphate and glutathione conjugates and is mediated by ATP-dependent protein transport 
systems - namely P-glycoprotein or MRPs [52, 53]. 
Protein transporters have a fundamental role in eliminating toxic compounds from the 
body [54]. In the present study, exposure to rac-KP resulted in a significant increase of MRP1, 
while cells exposed to DKP showed different mrp1 and mrp2 mRNAs expression levels, 
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compared to rac-KP. The effects of rac-KP on mrp1 and mrp2 expression levels could suggest a 
shorter cellular retention of rac-KP, compared to DKP. Thus, it is possible that rac-KP is excreted 
as unconjugated, conjugated by GST enzyme, or as glucuronide, prior to delivery for the phase 
III biotransformation process. On the other hand, DKP could remain within the cell for a longer 
period of time and could only be eliminated at the highest concentration. Although MRP 
expression has been demonstrated in several fish species [55], only limited reports are available 
on the regulation of these proteins, which are normally regulated at the protein level [56]. Thus, 
to the best of our knowledge, this is the first study in fish showing an increase of MRP mRNA by 
rac-KP and DKP, and as such these findings require further studies, in order to understand the 
pharmacological processes behind these effects.  
CONCLUSIONS 
This present study has demonstrated the importance of combining acute and chronic 
bioassays with studies of key detoxification systems at transcriptional and functional levels. This 
approach provides a better overview and understanding on the toxicological properties of 
pharmaceuticals that are commonly detected in the environment. Bacteria and algae exposed to 
DKP showed higher toxicity than those exposed to rac-KP. These NSAIDs did not exert 
cytotoxic effects in PLHC-1 cells. Nevertheless, rac-KP and DKP were observed to possibly act 
through different mechanism within the cells. Both NSAIDs interacted differently with CYP1A. 
In addition, the phase II biotransformation pathway showed different responses with significant 
increase and decrease in GST activity in cells treated with rac-KP and DKP, respectively. Lastly, 
rac-KP interacted with the efflux pump by increasing the expression levels, while DKP reduced 
it, except at the highest tested concentration. These results suggest that rac-KP and DKP have 
different toxicity effects on model organisms and different toxicological response mechanism in 
fish cell model. 
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Figure 1. Inhibition of growth in Pseudokirchneriella subcapitata (96 h incubation) exposed to 
different concentrations of rac-KP and DKP (expressed as Log concentration). Rac-KP, DKP and 
the calculated S(+) fraction of rac-KP are plotted as percentage of inhibition of control. Data are 
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presented as mean % of inhibition (symbols; n=3) and regression curves for each condition are 
represented as lines. 
Figure 2. Changes in cyp1a transcript and EROD activity levels in PLHC-1 cell-line exposed for 
48 and 72 h to rac-KP (A and B, respectively) and DKP (C and D, respectively). Data are 
presented as mean (n=3) percentage of control and standard deviation. Significant differences 
(two-way ANOVA, Tukey post-hoc test) were analyzed by comparing treated cells to the 
corresponding controls within the same exposure time (*p≤0.05; **p≤0.01 and ***p ≤0.001) and by 
comparing the same concentration at different exposure times (#p ≤0.05;  ##p ≤0.01 and ###p 
≤0.001). 
Figure 3. GST activity in PLHC-1 cell-line exposed to rac-KP (A) and  DKP (B) for 48 and 72 h. 
Data are presented as mean (n=3) percentage of control and standard deviation. Significant 
differences (two-way ANOVA, Tukey post-hoc test) were analyzed by comparing treated cells to 
the corresponding controls within the same exposure time (*p≤0.05; **p≤0.01 and ***p ≤0.001) 
and by comparing the same concentration at different exposure times (#p ≤0.05;  ##p ≤0.01 and 
###p ≤0.001). 
Figure 4. Changes in mrp1 and mrp2 transcript levels in PLHC-1 cell-line exposed for 48 and 72 
h to rac-KP (A and B, respectively) and DKP (C and D, respectively). Data are presented as 
mean (n=3) percentage of control and standard deviation. Significant differences (two-way 
ANOVA, Tukey post-hoc test) were analyzed by comparing treated cells to the corresponding 
controls within the same exposure time (*p≤0.05; **p≤0.01 and ***p ≤0.001) and by comparing the 
same concentration at different exposure times (#p ≤0.05;  ##p ≤0.01 and ###p ≤0.001). 
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Table 1. Primer pair sequences, amplicon size, annealing temperature and GenBank ID for genes 
amplified by real-time PCR. 
Gene Primer pairs sequences (5’-3’) 
Amplicon 
size (bp) 
Annealing      
T (°C) 
GenBank 
ID 
cyp1a 
 
Forward: GCATTTGGCGTGCTCGAAGAAA 
Reverse: TTGCAGATGTGCTCCTCCAACA 
109 60 JX270831.1 
mrp1 
 
Forward: GCCGTTCTCCTATCTACAC 
Reverse: GAGAGTGACCAGCGAGTA 
107 60 HM102361.1 
mrp2 
 
Forward: TGCTGCTGGTGGCTCTTCTAC 
Reverse: GCAAAGAGTCAACAGTCGGAGAAA 
159 60 HM102360.1 
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Table 2. Inhibition of bioluminescence in Vibrio fischeri (expressed as I%) exposed to different 
concentrations of rac-KP and DKP for 15 min. 
Rac-KP 
 (µg/L) 
I% 
15 min 
 DKP 
 (µg/L) 
I% 
15 min 
 
3.9 
 
3.3 
  
3.9 
 
-4.0 
 
7.8 
 
3.8 
  
7.8 
 
2.6 
 
15.6 
 
-0.5 
  
15.6 
 
-5.6 
 
31.3 
 
0.7 
  
31.3 
 
4.0 
 
62.5 
 
0.6 
  
62.5 
 
-0.9 
 
125 
 
0.9 
  
125 
 
4.9 
 
250 
 
-2.8 
  
250 
 
-0.3 
 
500 
 
-2.9 
  
500 
 
18.5 
 
1000 
 
-8.4 
  
1000 
 
28.7 
 
2000 
 
-17.9 
  
2000 
 
72.9 
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Table 3. Calculated NOEC, LOEC and EC5,10,20,50 values with confident limits (CL: in 
parentheses) in Pseudokirchneriella subcapitata exposed to different concentrations of rac-KP 
and DKP for 96 h. 
 
NSAIDs 
NOEC 
µg/L 
LOEC 
µg/L 
EC5  
µg/L 
EC10  
µg/L 
EC20  
µg/L 
EC50 
µg/L 
 
Rac-KP  
 
7.8 
 
15.6 
 
3.1 (1.1 - 10.5) 
 
9.0 (1.4 - 12.9) 
 
13.9 (4.8 - 32.2) 
 
240.2 (201.8 - 280.7) 
 
DKP 
 
3.9 
 
7.8 
 
2.9 (0.7 - 4.7) 
 
4.5 (1.6 - 6.6) 
 
7.4 (5.4 - 9.2) 
 
65.6 (40.6 - 72.3) 
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Table 4. Nominal and measured concentration of rac-KP (R(-)/S(+) KP) and DKP (S(+)KP) in 
algal test solutions. Data are expressed as mean ± standard deviation (n=3). 
 
 
Measured concentration  
of rac-KP* (µg/L) 
  
Measured concentration  
of DKP (µg/L) 
 
 
0 h 
  
96 h 
  
0 h 
 
96 h 
Nominal 
concentration 
(µg/L) 
 
R (-) 
 
S (+) 
  
R (-) 
 
S (+) 
  
S (+)  
 
S (+) 
 1.95 
 
0.99 ± 0.05 
 
1.11 ± 0.11 
  
0.90 ± 0.01 
 
0.99 ± 0.01 
 
1.99 ± 0.21 1.92 ± 0.10 
 3.90 2.03 ± 0.06 
 
1.96 ± 0.11 
  
1.90 ± 0.10 
 
1.91 ± 0.03 
 
3.97 ± 0.15 3.83 ± 0.06 
 7.81 4.03 ± 0.15 
 
3.96 ± 0.06 
 
3.83 ± 0.06 
 
3.90 ± 0.17 
 
8.06 ± 0.12 7.79 ± 0.22 
15.63 8.16 ± 0.29 
 
7.99 ± 0.11 
 
7.50 ± 0.50 
 
7.77 ± 0.25 
 
16.33 ± 0.58 14.9 ± 0.12 
31.25 16.1 ± 0.60 
 
15.93 ± 0.12 
 
14.90 ± 0.17 
 
15.17 ± 0.76 
 
32.10 ± 0.36 29.67 ± 0.58 
62.5 32.10±0.36 
 
32.00 ± 1.05 
 
29.67 ± 0.58 
 
29.67 ± 0.57 
 
64.77 ± 0.40 62.67 ± 3.79 
125 64.77 ± 0.40 
 
64.00 ± 2.65 
 
62.67 ± 3.79 
 
60.02 ± 1.05 
 
117.04 ± 2.65 113.31 ± 8.39 
250 124.70 ± 5.03   112.30 ± 6.66   251.72 ± 7.64 241.30±16.29 
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*Sum of 50% R and S enantiomers.  
 
 
120.70 ± 2.08 111.7 ± 7.64 
500 245.00 ± 5.00 
 
252.30 ± 6.81 
 
242.00 ± 13.11 
 
220.00 ± 10.01 
 
501.30 ± 4.93 483.00±11.27 
1000 501.01 ± 11.03 
 
488.70 ± 10.50 
 
476.70 ± 25.17 
 
448.70 ± 8.08 
 
1007.04 ± 11.22 990.01 ± 10.01 
2000 1004.00 ± 16.92 
 
992.30 ± 16.26 
 
986.71 ± 11.55 
 
933.32 ± 37.86 
 
2003.03 ± 15.72 1987.00 ± 15.28 
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Table 5. Percentage mortality/immobilization in Ceriodaphnia dubia after acute 48 h exposure to 
different concentrations of rac-KP and DKP. 
Rac-KP 
(µg/L) 
Mortality/ 
Immobilization 
(%) 
 
DKP  
(µg/L) 
Mortality/ 
Immobilization 
(%) 
Control 0.0  Control 0.0 
 
Solvent control  3.3 
  
Solvent control 3.3 
 
1560 13.3 
 
1560 10.0 
 
3130 20.0 
 
3130 10.0 
 
6250 23.3 
 
6250 23.3 
 
12500 23.3 
 
12500 23.3 
 
25000 23.3 
 
25000 26.7 
 
50000 26.7 
 
50000 30.0 
 
100000 40.0 
 
100000 60.0 
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Table 6. Reproduction and survival of Ceriodaphnia dubia following chronic 7-day exposure to 
different concentrations of rac-KP.  
   
Rac-KP 
 (µg/L) 
   
 
    
         Control 
 
1  
 
10  
 
100  
 
1000  
 
Time of first reproduction 
(days) ± SD 
Offspring/female ± SD 
 
Total reproduction 
 
Inhibited reproduction (%) 
 
Mortality (%) 
 
4 ± 0.0 
 
23.3 ± 1.9 
 
233 
 
- 
 
0 
 
4 ± 0.0 
 
18.7 ± 7.4 
 
187 
 
19.7 
 
0 
 
4 ± 0.0 
 
21.2 ± 2.5 
 
212 
 
9.1 
 
0 
 
     4 ± 0.0 
 
18.2 ± 1.5 
 
182 
 
21.9 
 
0 
 
4.3 ± 0.5 
 
17.5 ± 4.4* 
 
105 
 
24.9 
 
20 
*p < 0.05 (one-way ANOVA, Dunnett’s test) 
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Table 7. Reproduction and survival of Ceriodaphnia dubia following chronic 7-day exposure to 
different concentrations of DKP.  
   
DKP 
(µg/L) 
 
 
    
Control 
 
1  
 
10  
 
100  
 
1000  
 
Time of first reproduction  
(days) ± SD 
Offspring/female ± SD 
 
Total reproduction 
 
Inhibited reproduction (%) 
 
Mortality (%) 
 
4 ± 0.0 
 
20.5 ± 1.7 
 
205 
 
- 
 
0 
 
4 ± 0.0 
 
18.2 ± 2.2 
 
182 
 
11.2 
 
0 
 
4 ± 0.0 
 
17.4 ± 1.8 
 
174 
 
15.1 
 
0 
 
4.4 ± 0.5 
 
14.6 ± 2.6* 
 
117 
 
28.8 
 
20 
 
4.6 ± 0.5 
 
11.2 ± 1.6* 
 
67 
 
45.4 
 
40 
*p < 0.05 (one-way ANOVA, Dunnett’s test) 
A
cc
ep
te
d 
Pr
ep
ri
nt
This article is protected by copyright. All rights reserved 
 
Table 8. Nominal and measured concentration of rac-KP (R(-)/S(+) KP) and DKP (S(+)KP) in 
crustacean test solutions. Data are expressed as mean ± standard deviation (n=3). 
 
 
Measured concentration  
Of rac-KP* (µg/L) 
  
Measured concentration  
of DKP (µg/L) 
 
 
0 d 
  
7 d 
  
0 d 
 
7 d 
Nominal 
concentration 
(µg/L) 
 
R (-) 
 
S (+) 
  
R (-) 
 
S (+) 
  
S (+) 
 
S (+) 
1 
 
0.43 ± 0.06 
 
0.60 ± 0.10 
  
0.63 ± 0.20 
 
0.60 ± 0.26 
  
1.10 ± 0.10 
                   
0.97 ± 0.15 
10 4.50 ± 0.50 
 
4.53 ± 0.50 
  
5.00 ± 0.10 
 
4.53 ± 0.50 
   
9.50 ± 0.50 
 
9.62 ± 1.22 
100 47.33 ± 3.79 
 
49.00 ± 6.25 
 
45.67 ± 3.06 
 
42.33 ± 4.04 
  
104.02 ± 5.29 
                 
95.67 ± 5.86 
1000 489.70 ± 10.02 
 
486.00 ± 6.93 
 
453.30 ± 15.28 
 
456.70 ± 37.86 
  
996.70 ± 25.17 
                
993.32 ± 25.11 
*Sum of 50% R and S enantiomers.  
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